Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells

Cell

Volumn 164, Issue 3, 2016, Pages 365-377

  Dadi, Saïda ^a   Chhangawala, Sagar ^a,b   Whitlock, Benjamin M ^a,b   Franklin, Ruth A ^a,b   Luo, Chong T ^a   Oh, Soyoung A ^a   Toure, Ahmed ^a   Pritykin, Yuri ^a   Huse, Morgan ^a   Leslie, Christina S ^a   Li, Ming O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTEGRIN; CD103 ANTIGEN; GRANZYME B; INTERLEUKIN 15; NK1.1 PROTEIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFIL3; TUMOR ANTIGEN; UNCLASSIFIED DRUG; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; GRANZYME; LYMPHOCYTE ANTIGEN RECEPTOR; NFIL3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOLOGY; CELL LINEAGE; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOID CELL; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; ONCOGENE; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; ANIMAL; C57BL MOUSE; EXPERIMENTAL MAMMARY NEOPLASM; IMMUNOLOGICAL MONITORING; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; GRANZYMES; INTERLEUKIN-15; LYMPHOCYTES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MONITORING, IMMUNOLOGIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS;

EID: 84955561954     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.01.002     Document Type: Article

References (62)

1. D. Artis, and H. Spits The biology of innate lymphoid cells Nature 517 2015 293 301
2. J.H. Bernink, C.P. Peters, M. Munneke, A.A. te Velde, S.L. Meijer, K. Weijer, H.S. Hreggvidsdottir, S.E. Heinsbroek, N. Legrand, C.J. Buskens, and et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues Nat. Immunol. 14 2013 221 229
3. J.H. Bernink, L. Krabbendam, K. Germar, E. de Jong, K. Gronke, M. Kofoed-Nielsen, J.M. Munneke, M.D. Hazenberg, J. Villaudy, C.J. Buskens, and et al. Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria Immunity 43 2015 146 160
4. P.R. Burkett, R. Koka, M. Chien, S. Chai, D.L. Boone, and A. Ma Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis J. Exp. Med. 200 2004 825 834
5. M. Burnet Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications BMJ 1 1957 841 847
6. H. Cheroutre, F. Lambolez, and D. Mucida The light and dark sides of intestinal intraepithelial lymphocytes Nat. Rev. Immunol. 11 2011 445 456
7. M.G. Constantinides, B.D. McDonald, P.A. Verhoef, and A. Bendelac A committed precursor to innate lymphoid cells Nature 508 2014 397 401
8. V.S. Cortez, A. Fuchs, M. Cella, S. Gilfillan, and M. Colonna Cutting edge: Salivary gland NK cells develop independently of Nfil3 in steady-state J. Immunol. 192 2014 4487 4491
9. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
10. C. Daussy, F. Faure, K. Mayol, S. Viel, G. Gasteiger, E. Charrier, J. Bienvenu, T. Henry, E. Debien, U.A. Hasan, and et al. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow J. Exp. Med. 211 2014 563 577
11. J. Deguine, B. Breart, F. Lemaître, J.P. Di Santo, and P. Bousso Intravital imaging reveals distinct dynamics for natural killer and CD8(+) T cells during tumor regression Immunity 33 2010 632 644
12. T.L. Denning, S.W. Granger, D. Mucida, R. Graddy, G. Leclercq, W. Zhang, K. Honey, J.P. Rasmussen, H. Cheroutre, A.Y. Rudensky, and M. Kronenberg Mouse TCRalphabeta+CD8alphaalpha intraepithelial lymphocytes express genes that down-regulate their antigen reactivity and suppress immune responses J. Immunol. 178 2007 4230 4239
13. A. Diefenbach, M. Colonna, and S. Koyasu Development, differentiation, and diversity of innate lymphoid cells Immunity 41 2014 354 365
14. M.K. Donkor, A. Sarkar, P.A. Savage, R.A. Franklin, L.K. Johnson, A.A. Jungbluth, J.P. Allison, and M.O. Li T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine Immunity 35 2011 123 134
15. M. DuPage, C. Mazumdar, L.M. Schmidt, A.F. Cheung, and T. Jacks Expression of tumour-specific antigens underlies cancer immunoediting Nature 482 2012 405 409
16. G. Eberl, M. Colonna, J.P. Di Santo, and A.N. McKenzie Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology Science 348 2015 aaa6566
17. P. Ehrlich Uber den jetzigen stand der karzinomforschung Ned. Tijdschr. Geneeskd. 5 1909 273 290
18. T. Enzler, S. Gillessen, J.P. Manis, D. Ferguson, J. Fleming, F.W. Alt, M. Mihm, and G. Dranoff Deficiencies of GM-CSF and interferon gamma link inflammation and cancer J. Exp. Med. 197 2003 1213 1219
19. N. Finnberg, A.J. Klein-Szanto, and W.S. El-Deiry TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis J. Clin. Invest. 118 2008 111 123
20. R.A. Franklin, W. Liao, A. Sarkar, M.V. Kim, M.R. Bivona, K. Liu, E.G. Pamer, and M.O. Li The cellular and molecular origin of tumor-associated macrophages Science 344 2014 921 925
21. A. Fuchs, W. Vermi, J.S. Lee, S. Lonardi, S. Gilfillan, R.D. Newberry, M. Cella, and M. Colonna Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells Immunity 38 2013 769 781
22. D.M. Gascoyne, E. Long, H. Veiga-Fernandes, J. de Boer, O. Williams, B. Seddon, M. Coles, D. Kioussis, and H.J. Brady The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development Nat. Immunol. 10 2009 1118 1124
23. T.L. Geiger, M.C. Abt, G. Gasteiger, M.A. Firth, M.H. O'Connor, C.D. Geary, T.E. O'Sullivan, M.R. van den Brink, E.G. Pamer, A.M. Hanash, and J.C. Sun Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens J. Exp. Med. 211 2014 1723 1731
24. A.E. Gillgrass, M.V. Chew, T. Krneta, and A.A. Ashkar Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model BMC Cancer 15 2015 293
25. N.M. Greenberg, F. DeMayo, M.J. Finegold, D. Medina, W.D. Tilley, J.O. Aspinall, G.R. Cunha, A.A. Donjacour, R.J. Matusik, and J.M. Rosen Prostate cancer in a transgenic mouse Proc. Natl. Acad. Sci. USA 92 1995 3439 3443
26. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
27. N. Guerra, Y.X. Tan, N.T. Joncker, A. Choy, F. Gallardo, N. Xiong, S. Knoblaugh, D. Cado, N.M. Greenberg, and D.H. Raulet NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy Immunity 28 2008 571 580
28. A. Iannello, T.W. Thompson, M. Ardolino, S.W. Lowe, and D.H. Raulet p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells J. Exp. Med. 210 2013 2057 2069
29. B. Jabri, and L.M. Sollid Tissue-mediated control of immunopathology in coeliac disease Nat. Rev. Immunol. 9 2009 858 870
30. S. Kamizono, G.S. Duncan, M.G. Seidel, A. Morimoto, K. Hamada, G. Grosveld, K. Akashi, E.F. Lind, J.P. Haight, P.S. Ohashi, and et al. Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo J. Exp. Med. 206 2009 2977 2986
31. M. Kashiwada, D.M. Levy, L. McKeag, K. Murray, A.J. Schröder, S.M. Canfield, G. Traver, and P.B. Rothman IL-4-induced transcription factor NFIL3/E4BP4 controls IgE class switching Proc. Natl. Acad. Sci. USA 107 2010 821 826
32. C.S. Klose, M. Flach, L. Möhle, L. Rogell, T. Hoyler, K. Ebert, C. Fabiunke, D. Pfeifer, V. Sexl, D. Fonseca-Pereira, and et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages Cell 157 2014 340 356
33. C.M. Koebel, W. Vermi, J.B. Swann, N. Zerafa, S.J. Rodig, L.J. Old, M.J. Smyth, and R.D. Schreiber Adaptive immunity maintains occult cancer in an equilibrium state Nature 450 2007 903 907
34. A. Le Floc'h, A. Jalil, I. Vergnon, B. Le Maux Chansac, V. Lazar, G. Bismuth, S. Chouaib, and F. Mami-Chouaib Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis J. Exp. Med. 204 2007 559 570
35. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
36. J. Marks-Konczalik, S. Dubois, J.M. Losi, H. Sabzevari, N. Yamada, L. Feigenbaum, T.A. Waldmann, and Y. Tagaya IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice Proc. Natl. Acad. Sci. USA 97 2000 11445 11450
37. H. Matsushita, M.D. Vesely, D.C. Koboldt, C.G. Rickert, R. Uppaluri, V.J. Magrini, C.D. Arthur, J.M. White, Y.S. Chen, L.K. Shea, and et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting Nature 482 2012 400 404
38. P. Matzinger The danger model: a renewed sense of self Science 296 2002 301 305
39. S. Mayans, D. Stepniak, S.F. Palida, A. Larange, J. Dreux, B.M. Arlian, R. Shinnakasu, M. Kronenberg, H. Cheroutre, and F. Lambolez αβT cell receptors expressed by CD4(-)CD8αβ(-) intraepithelial T cells drive their fate into a unique lineage with unusual MHC reactivities Immunity 41 2014 207 218
40. B.D. McDonald, J.J. Bunker, I.E. Ishizuka, B. Jabri, and A. Bendelac Elevated T cell receptor signaling identifies a thymic precursor to the TCRαβ(+)CD4(-)CD8β(-) intraepithelial lymphocyte lineage Immunity 41 2014 219 229
41. B. Mlecnik, G. Bindea, H.K. Angell, M.S. Sasso, A.C. Obenauf, T. Fredriksen, L. Lafontaine, A.M. Bilocq, A. Kirilovsky, M. Tosolini, and et al. Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients Sci. Transl. Med. 6 2014 228ra37
42. D. Pardoll Does the immune system see tumors as foreign or self? Annu. Rev. Immunol. 21 2003 807 839
43. H. Peng, X. Jiang, Y. Chen, D.K. Sojka, H. Wei, X. Gao, R. Sun, W.M. Yokoyama, and Z. Tian Liver-resident NK cells confer adaptive immunity in skin-contact inflammation J. Clin. Invest. 123 2013 1444 1456
44. D.H. Raulet, S. Gasser, B.G. Gowen, W. Deng, and H. Jung Regulation of ligands for the NKG2D activating receptor Annu. Rev. Immunol. 31 2013 413 441
45. M.L. Robinette, A. Fuchs, V.S. Cortez, J.S. Lee, Y. Wang, S.K. Durum, S. Gilfillan, M. Colonna Immunological Genome Consortium Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets Nat. Immunol. 16 2015 306 317
46. P.A. Savage, K. Vosseller, C. Kang, K. Larimore, E. Riedel, K. Wojnoonski, A.A. Jungbluth, and J.P. Allison Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes Science 319 2008 215 220
47. R.D. Schreiber, L.J. Old, and M.J. Smyth Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion Science 331 2011 1565 1570
48. C. Seillet, L.C. Rankin, J.R. Groom, L.A. Mielke, J. Tellier, M. Chopin, N.D. Huntington, G.T. Belz, and S. Carotta Nfil3 is required for the development of all innate lymphoid cell subsets J. Exp. Med. 211 2014 1733 1740
49. N. Serafini, C.A. Vosshenrich, and J.P. Di Santo Transcriptional regulation of innate lymphoid cell fate Nat. Rev. Immunol. 15 2015 415 428
50. V. Shankaran, H. Ikeda, A.T. Bruce, J.M. White, P.E. Swanson, L.J. Old, and R.D. Schreiber IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity Nature 410 2001 1107 1111
51. M.J. Smyth, K.Y. Thia, S.E. Street, D. MacGregor, D.I. Godfrey, and J.A. Trapani Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma J. Exp. Med. 192 2000 755 760
52. D.K. Sojka, B. Plougastel-Douglas, L. Yang, M.A. Pak-Wittel, M.N. Artyomov, Y. Ivanova, C. Zhong, J.M. Chase, P.B. Rothman, J. Yu, and et al. Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells eLife 3 2014 e01659
53. H. Spits, D. Artis, M. Colonna, A. Diefenbach, J.P. Di Santo, G. Eberl, S. Koyasu, R.M. Locksley, A.N. McKenzie, R.E. Mebius, and et al. Innate lymphoid cells - a proposal for uniform nomenclature Nat. Rev. Immunol. 13 2013 145 149
54. F. Stevenaert, K. Van Beneden, A. De Creus, V. Debacker, J. Plum, and G. Leclercq Ly49E expression points toward overlapping, but distinct, natural killer (NK) cell differentiation kinetics and potential of fetal versus adult lymphoid progenitors J. Leukoc. Biol. 73 2003 731 738
55. S.E. Street, N. Zerafa, M. Iezzi, J.A. Westwood, J. Stagg, P. Musiani, and M.J. Smyth Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma Cancer Res. 67 2007 5454 5460
56. K. Takeda, E. Cretney, Y. Hayakawa, T. Ota, H. Akiba, K. Ogasawara, H. Yagita, K. Kinoshita, K. Okumura, and M.J. Smyth TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver Blood 105 2005 2082 2089
57. L. Thomas Delayed hypersensitivity in health and disease H.S. Lawrence, Cellular and Humoral Aspects of the Hypersensitive States 1959 Hoeber-Harper 529 532
58. K. Van Beneden, A. De Creus, F. Stevenaert, V. Debacker, J. Plum, and G. Leclercq Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes J. Immunol. 168 2002 3295 3302
59. M. Wencker, G. Turchinovich, R. Di Marco Barros, L. Deban, A. Jandke, A. Cope, and A.C. Hayday Innate-like T cells straddle innate and adaptive immunity by altering antigen-receptor responsiveness Nat. Immunol. 15 2014 80 87
60. G. Willimsky, and T. Blankenstein Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance Nature 437 2005 141 146
61. N. Zerafa, J.A. Westwood, E. Cretney, S. Mitchell, P. Waring, M. Iezzi, and M.J. Smyth Cutting edge: TRAIL deficiency accelerates hematological malignancies J. Immunol. 175 2005 5586 5590
62. N. Zhang, and M.J. Bevan CD8(+) T cells: foot soldiers of the immune system Immunity 35 2011 161 168